The real tragedy on Married At First Sight that Australia should be talking about....
8 March 2017
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.
Whilst public discussion focuses on Cheryl and Andrew’s tumultuous relationship, we should be talking about something far more sinister. At their ‘relationship boot camp’ Cheryl was clearly shown sporting badly sunburnt shoulders and back. Her skin was bright red, it looked painful, and I’m sure viewers noticed. Yet no-one batted an eyelid.
Well, I am calling it. The national discussion about young Australians and melanoma needs to start, and it needs to start now. Our young adults are dying from melanoma. Sons, daughters, brothers, sisters, young parents – lost to melanoma, Australia’s national cancer, at the prime of their lives.
Melanoma is the most common cancer affecting 15-39 year-old Australians. It kills more 20-39 year olds than any other single cancer. One Australian dies from melanoma every six hours. Yet, it is largely preventable.
Intense, intermittent UV exposure leading to sunburn radically increases your chance of developing potentially deadly melanoma. So why are we sitting back and admiring a young woman with a bad case of sunburn on an Australian reality television show, and not discussing it?
Time to get with the program. The famous line, “I love a sunburnt country”, was written way back in 1908. Sun tanning products became sunscreen products back in the 80s, for a reason. Television shows moved on from showing contestants driving without seatbelts, or smoking, to send the right public health and safety messages. It is time to place the same importance on sending life-saving sun safety messages to impressionable young Australians. We banned sunbeds (another driver for melanoma), time to ban sunburn.
Cheryl’s sunburn was front and centre during Melanoma March, our annual awareness month, when I meet a truly heart-wrenching number of partners and parents who have lost their loved ones to melanoma at 24, 32 or 38. Come on Australia, who is ready to join the conversation and help us end melanoma?
CEO, Melanoma Institute Australia
For more information, please contact: Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | email@example.com
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.